Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products.
As per reports, Pfizer declared the election of Dr. Susan Hockfield to its Board of Directors. Dr. Hockfield will be added immediately & will also be serving as the Regulatory & Compliance Committee and the Science and Technology Committee of Pfizer’s Board. She completed a B.S. in Biology from the University of Rochester and a Ph.D. in Anatomy and Neuroscience from Georgetown University School of Medicine.
Dr. Hockfield also serves as Professor of Neuroscience and President Emerita at the Massachusetts Institute of Technology. She was the first woman and the first life scientist to lead MIT. Hockfield is also a member of the Koch Institute for Integrative Cancer Research at MIT and the American Association for the Advancement of Sciences.
To learn more about Pfizer (PFE) and to track its progress please visit the Vista Partners Pfizer Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.
feb2(15)
